Showing 321 - 340 results of 28,075 for search '(( 50 ((((we decrease) OR (mean decrease))) OR (a decrease)) ) OR ( 5 ht decrease ))', query time: 0.97s Refine Results
  1. 321
  2. 322
  3. 323
  4. 324
  5. 325
  6. 326
  7. 327
  8. 328

    Comparison of the effects of several 5-HT receptor antagonists on the plasma concentrations of metabolites and insulin, following 5-HT injection in sheep and mice. by Hitoshi Watanabe (519631)

    Published 2014
    “…a<p>Murine data published previously [Ref. 16].</p>b<p>5-HT: serotonin; Me: methysergide; Ke: ketanserin; SB-26: SB-269970; SB-20: SB-204070; Ro: Ro 04-6790; I: increase; D: decrease; N: no change; +: effective in blocking the effect of 5-HT; −: ineffective in blocking the effect of 5-HT.…”
  9. 329

    HDM exposure results in increased MIP-2 and decreased IFNα and IL-13. by Jennifer A. Phan (535730)

    Published 2014
    “…HDM exposure increased bronchoalveolar lavage MIP-2 (A), and decreased IFNα (B) and IL13 (C). There was no effect of HDM exposure on BAL protein (D), nor were there any effects of HRV-1B infection alone, or combined effects of HDM exposure and HRV-1B infection on any of these parameters. * indicates a significant difference between groups. …”
  10. 330
  11. 331
  12. 332
  13. 333
  14. 334
  15. 335
  16. 336
  17. 337

    Effect of 2% HQ, 0.05% INN and 0.1% TAC on hippocampal 5-HT level and 5-HT<sub>1A /1B</sub> receptor expression. by Huali Wu (349567)

    Published 2016
    “…Scale bar = 50μm. (C) IOD values of the expression of 5-HT<sub>1A</sub> receptor in CA1 region. …”
  18. 338
  19. 339

    Synthesis and Biological Evaluation of Peripheral 5HT<sub>2B</sub> Antagonists for Liver Fibrosis by Jihyeon Yoon (8705706)

    Published 2025
    “…<b>19c</b> markedly reduced fibrotic deposition, with a decrease in fibrosis stage and area in the CCl<sub>4</sub>-induced liver fibrosis mouse model. …”
  20. 340

    Synthesis and Biological Evaluation of Peripheral 5HT<sub>2B</sub> Antagonists for Liver Fibrosis by Jihyeon Yoon (8705706)

    Published 2025
    “…<b>19c</b> markedly reduced fibrotic deposition, with a decrease in fibrosis stage and area in the CCl<sub>4</sub>-induced liver fibrosis mouse model. …”